
TY  - JOUR
AU  - Purroy, F.
AU  - Suárez-Luis, I.
AU  - Cambray, S.
AU  - Farré, J.
AU  - Benabdelhak, I.
AU  - Mauri-Capdevila, G.
AU  - Sanahuja, J.
AU  - Quílez, A.
AU  - Begué, R.
AU  - Gil, M. I.
AU  - Molina-Seguin, J.
AU  - Torreguitart, N.
TI  - The determination of copeptin levels helps management decisions among transient ischaemic attack patients
JO  - Acta Neurologica Scandinavica
JA  - Acta Neurol Scand
VL  - 134
IS  - 2
SN  - 0001-6314
UR  - https://doi.org/10.1111/ane.12523
DO  - doi:10.1111/ane.12523
SP  - 140
EP  - 147
KW  - biomarker
KW  - transient ischaemic attack
KW  - copeptin
KW  - prognosis
PY  - 2016
AB  - Background Most approaches to transient ischaemic attack (TIA) triage use clinical scores and vascular imaging; however, some biomarkers have been suggested to improve the prognosis of TIA patients. Methods Serum levels of copeptin, adiponectin, neopterin, neuron-specific enolase, high-sensitivity C-reactive protein, IL-6, N-terminal pro-B-type natriuretic peptide, S100?, tumour necrosis factor-alpha and IL-1α as well as clinical characteristics were assessed on consecutive TIA patients during the first 24 h of the onset of symptoms. Results Among 237 consecutive TIA patients, 12 patients (5%) had a stroke within 7 days and 15 (6%) within 90 days. Among all candidate biomarkers analysed, only copeptin was significantly increased in patients with stroke recurrence (SR) within 7 days (P = 0.026) but not within 90 days. A cut-off point of 13.8 pmol/l was established with a great predictive negative value (97.4%). Large artery atherosclerosis (LAA) [hazard ratio (HR) 12.7, 95% CI 3.2?50.1, P < 0.001] and copeptin levels ≥13.8 pmol/l (HR 3.9, 95% CI 1.01?14.4, P = 0.039) were independent predictors of SR at the 7-day follow-up. LAA was the only predictor of 90-day SR (HR 7.4, 95% CI 2.5?21.6, P < 0.001). ABCD3I was associated with 7- and 90-day SRs (P = 0.025 and P = 0.034, respectively). The association between copeptin levels and LAA had a diagnostic accuracy of 90.3%. Conclusions Serum copeptin could be an important prognostic biomarker to guide management decisions among TIA patients. Therefore, TIA patients with copeptin levels below 13.8 pmol/l and without LAA have an insignificant risk of 7-day SR and could be managed on an outpatient basis.
ER  - 

TY  - JOUR
TI  - Administrative Operations
JO  - Transfusion
VL  - 46
IS  - 9s
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.2006.01023_2.x
DO  - doi:10.1111/j.1537-2995.2006.01023_2.x
SP  - 165A
EP  - 233A
PY  - 2006
ER  - 

TY  - JOUR
TI  - ISLH 2017 Abstract Proceedings
JO  - International Journal of Laboratory Hematology
JA  - Int. Jnl. Lab. Hem.
VL  - 39
IS  - S2
SN  - 1751-5521
UR  - https://doi.org/10.1111/ijlh.12698
DO  - doi:10.1111/ijlh.12698
SP  - 3
EP  - 133
PY  - 2017
ER  - 

TY  - JOUR
C7  - e26591
TI  - 2017 ASPHO ABSTRACTS
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 64
IS  - S1
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.26591
DO  - doi:10.1002/pbc.26591
SP  - e26591
PY  - 2017
ER  - 

TY  - JOUR
TI  - 44th Congress of the International Society of Paediatric Oncology (SIOP) 2012, London, United Kingdom, 5th–8th October, 2012 SIOP abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 59
IS  - 6
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.24295
DO  - doi:10.1002/pbc.24295
SP  - 965
EP  - 1152
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Diabetes Investigation
JA  - J Diabetes Investig
VL  - 10
IS  - S1
SN  - 2040-1116
UR  - https://doi.org/10.1111/jdi.13033
DO  - doi:10.1111/jdi.13033
SP  - 24
EP  - 44
PY  - 2019
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Journal of Paediatrics and Child Health
VL  - 43
IS  - s1
SN  - 1034-4810
UR  - https://doi.org/10.1111/j.1440-1754.2007.01097.x
DO  - doi:10.1111/j.1440-1754.2007.01097.x
SP  - A12
EP  - A77
PY  - 2007
ER  - 

TY  - JOUR
TI  - ASBMR 25th Annual Meeting M001–M483
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 18
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650181306
DO  - doi:10.1002/jbmr.5650181306
SP  - S285
EP  - S393
PY  - 2003
ER  - 

TY  - JOUR
AU  - Jacewicz-Święcka, Małgorzata
AU  - Kowalska, Irina
C7  - e3054
C8  - DMRR-18-REV-004.R2
TI  - Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies
JO  - Diabetes/Metabolism Research and Reviews
JA  - Diabetes Metab Res Rev
VL  - 34
IS  - 8
SN  - 1520-7552
UR  - https://doi.org/10.1002/dmrr.3054
DO  - doi:10.1002/dmrr.3054
SP  - e3054
KW  - cardiometabolic complications
KW  - longitudinal studies
KW  - PCOS
KW  - review
PY  - 2018
AB  - Summary The purpose of this study was to perform a review of the longitudinal studies to determine whether polycystic ovary syndrome is associated with higher prevalence of metabolic complications and cardiovascular morbidity and mortality. The primary outcomes included body mass index, metabolic syndrome and its components (waist circumference, lipid profile, arterial hypertension, abnormal glucose metabolism (impaired fasting glucose, impaired glucose tolerance, type 2 diabetes), insulin resistance, and cardiovascular diseases like stroke, angina, and coronary heart disease. Complications in pregnant women were beyond the scope of this review. PubMed database (1992-2018) was searched to identify proper publications. Finally, data from 47 articles were analysed. Studies differed in the design (prospective, retrospective, cohort, observational), research methods, polycystic ovary syndrome diagnostic criteria, studied populations, race, and ethnicity of the participants. Based on the data collected, it appears that women with polycystic ovary syndrome have higher prevalence of obesity, abdominal fat distribution, dyslipidaemia and deterioration of glucose metabolism, but increased prevalence of cardiovascular diseases is not proven.
ER  - 

TY  - JOUR
TI  - Acta Prize Oral Presentations
JO  - Acta Anaesthesiologica Scandinavica
JA  - Acta Anaesthesiol Scand
VL  - 57
IS  - S120
SN  - 0001-5172
UR  - https://doi.org/10.1111/aas.12152
DO  - doi:10.1111/aas.12152
SP  - 1
EP  - 3
PY  - 2013
ER  - 

TY  - JOUR
TI  - Retina, Vitreous
JO  - Clinical & Experimental Ophthalmology
VL  - 36
IS  - s1
SN  - 1442-6404
UR  - https://doi.org/10.1111/j.1442-9071.2008.01760.x
DO  - doi:10.1111/j.1442-9071.2008.01760.x
SP  - A459
EP  - A584
PY  - 2008
ER  - 

TY  - JOUR
TI  - Oral Sessions
JO  - International Journal of Paediatric Dentistry
VL  - 21
IS  - s1
SN  - 0960-7439
UR  - https://doi.org/10.1111/j.1365-263X.2011.01137.x
DO  - doi:10.1111/j.1365-263X.2011.01137.x
SP  - 1
EP  - 66
PY  - 2011
ER  - 

TY  - JOUR
TI  - Oral Sessions
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 26
IS  - S1
SN  - 1351-5101
UR  - https://doi.org/10.1111/ene.14017
DO  - doi:10.1111/ene.14017
SP  - 16
EP  - 111
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Colorectal Disease
JA  - Colorectal Dis
VL  - 20
IS  - S4
SN  - 1462-8910
UR  - https://doi.org/10.1111/codi.14329
DO  - doi:10.1111/codi.14329
SP  - 33
EP  - 140
PY  - 2018
ER  - 

TY  - JOUR
TI  - Posters: Basic and clinical science posters: Beta-cells and islets
JO  - Diabetic Medicine
VL  - 27
IS  - s1
SN  - 0742-3071
UR  - https://doi.org/10.1111/j.1464-5491.2009.02936.x
DO  - doi:10.1111/j.1464-5491.2009.02936.x
SP  - 37
EP  - 188
PY  - 2010
ER  - 

TY  - JOUR
TI  - E-Poster Exhibition | APDW 2019
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 34
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.14865
DO  - doi:10.1111/jgh.14865
SP  - 583
EP  - 853
PY  - 2019
ER  - 

TY  - JOUR
TI  - Contributed Poster Presentations
JO  - Value in Health
VL  - 10
IS  - 6
SN  - 1098-3015
UR  - https://doi.org/10.1111/j.1524-4733.2007.00263_2.x
DO  - doi:10.1111/j.1524-4733.2007.00263_2.x
SP  - A243
EP  - A475
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Colorectal Disease
JA  - Colorectal Dis
VL  - 17
IS  - S2
SN  - 1462-8910
UR  - https://doi.org/10.1111/codi.13053
DO  - doi:10.1111/codi.13053
SP  - 38
EP  - 101
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - International Journal of Stroke
JA  - Int J Stroke
VL  - 9
IS  - S3
SN  - 1747-4930
UR  - https://doi.org/10.1111/ijs.12367
DO  - doi:10.1111/ijs.12367
SP  - 41
EP  - 331
PY  - 2014
ER  - 

TY  - JOUR
TI  - AMERICAN ACADEMY OF PAIN MEDICINE ANNUAL MEETING ABSTRACTS—2009
JO  - Pain Medicine
VL  - 10
IS  - 1
SN  - 1526-2375
UR  - https://doi.org/10.1111/j.1526-4637.2008.00537.x
DO  - doi:10.1111/j.1526-4637.2008.00537.x
SP  - 199
EP  - 278
PY  - 2009
ER  - 
